National Bank of Canada
NUVB icon

National Bank of Canada’s Nuvation Bio NUVB Stock Holding History

National Bank of Canada’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.46K Buy
+575
New +$3.2K ﹤0.01% 2589
2025
Q4 		– Sell
-3,300
Closed -$12.2K – 3058
2025
Q3 		$12.2K Buy
+3,300
New +$8.99K ﹤0.01% 2277
2024
Q4 		– Sell
-7
Closed -$16 – 3126
2024
Q3 		$16 Buy
+7
New +$21 ﹤0.01% 2662

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

National Bank of Canada's NUVB Position: Q1 2026 in Review

National Bank of Canada opened a new position in Nuvation Bio (NUVB) in Q1 2026: 575 shares worth $2.46K. The stake represents ﹤0.01% of the portfolio and ranks #2589 among its holdings. This is a return to the name: National Bank of Canada previously reported a position in NUVB as recently as Q3 2025.

National Bank of Canada first reported a position in NUVB in Q3 2024 and has held it in 3 quarters since. The position peaked at $12.2K in Q3 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • National Bank of Canada held 575 shares of Nuvation Bio worth $2.46K as of Q1 2026.
  • Nuvation Bio was a new National Bank of Canada position in Q1 2026.
  • Nuvation Bio made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2589 holding.
  • National Bank of Canada first reported a position in Nuvation Bio in Q3 2024 and has held it in 3 quarters since.
  • National Bank of Canada's Nuvation Bio position peaked at $12.2K in Q3 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.